Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017  Document date: 2017_11_7
                    ID: roslkxeq_55
                    
                    Snippet: Respiratory failure due to cardiogenic pulmonary edema secondary to MVD is a very common disease in dogs; in this study, CPAP-helmet interface was a valid alternative to oxygen flow-by therapy. Though clinical improvement was similar in the first 30 min, CPAP-helmet reduced the need for butorphanol administration, quickened both clinical and radiographic signs of pulmonary edema improvement and showed a decrease of the mortality rate compared to .....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Respiratory failure due to cardiogenic pulmonary edema secondary to MVD is a very common disease in dogs; in this study, CPAP-helmet interface was a valid alternative to oxygen flow-by therapy. Though clinical improvement was similar in the first 30 min, CPAP-helmet reduced the need for butorphanol administration, quickened both clinical and radiographic signs of pulmonary edema improvement and showed a decrease of the mortality rate compared to oxygen flow-by. CPAP-helmet was well tolerated by all dogs.
 
  Search related documents: 
                                Co phrase  search for related documents- butorphanol administration and oxygen flow: 1
  - clinical improvement and common disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
  - clinical improvement and edema improvement: 1
  - clinical improvement and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70
  - clinical improvement and mortality rate decrease: 1, 2
  - clinical improvement and oxygen flow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
  - clinical improvement and pulmonary edema improvement: 1
  - clinical improvement and respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
  - clinical improvement and therapy oxygen flow: 1, 2, 3, 4, 5, 6, 7, 8, 9
  - common disease and dog common disease: 1
  - common disease and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68
  - common disease and oxygen flow: 1, 2, 3, 4, 5
  - common disease and respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
  - common disease and therapy oxygen flow: 1, 2
  - cpap helmet and mortality rate: 1, 2
  - cpap helmet and oxygen flow: 1, 2, 3, 4
  - cpap helmet and respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
  - cpap helmet and therapy oxygen flow: 1, 2
  - cpap helmet interface and respiratory failure: 1
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date